drugset
drugset / Trial / NCT05712681

Clinical Trial to Evaluate Food-Effects on Pharmacokinetics and Pharmacodynamics of Oral Single Dose of JP-1366 Tablet in Healthy Volunteers

NCT05712681 ↗

Phase 1 Completed 24 enrolled Onconic Therapeutics Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

To Evaluate Food-Effects on Pharmacokinetics and Pharmacodynamics of Oral single dose of JP-1366 tablet in Healthy volunteers

Timeline

Start
2023-03-29
Primary completion
2023-05-04
Completion
2023-05-18

Drugs

EvaluationDrugModalityDoseRoute
Subject JP-1366 Unknown 20 mg Oral

Indications

No indication recorded.